Dance as a performative art form enhanced identity negotiation and strengthened group identity in people with Parkinson’s disease. A recent study by the University of Eastern Finland and Balettakademien Stockholm found that performing in a dance company and being involved in its activities play a significant role in the identity and disease-related identity negotiation in […]
Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been associated with a reduced risk of Parkinson’s disease in some previous epidemiological studies, this association was not found in a recent register-based study from the University of Eastern Finland. The findings were published […]
Read More… from Beta-2 agonists not associated with a lower risk of Parkinson’s
The results of a multi-site clinical study analysing the performance of PDMonitor, a pioneering Parkinson’s Disease monitoring device from PD Neurotechnology that uses wearables and Artificial Intelligence (AI) to track and assess symptoms, have been published in Frontiers in Neurology, a leading peer-reviewed clinical neurology journal. The study compared PDMonitor’s automated assessments of Parkinson’s patients […]
How the brain’s recycling system breaks down in Parkinson’s Disease: Researchers from the University of Queensland have identified that a gene associated with an increased risk of Parkinson’s Disease also contributes to a build-up of cell debris in the brain. Dr Adekunle Bademosi from The Queensland Brain Institute said the discovery could change the focus […]
Read More… from How the brain’s recycling system breaks down in Parkinson’s Disease
‘A silent killer’ – COVID-19 shown to trigger inflammation in the brain: The UQ team was led by Professor Trent Woodruff and Dr Eduardo Albornoz Balmaceda from UQ’s School of Biomedical Sciences, and virologists from the School of Chemistry and Molecular Biosciences. “We studied the effect of the virus on the brain’s immune cells, ‘microglia’ […]
Read More… from ‘A silent killer’ – COVID-19 shown to trigger inflammation in the brain
Wireless neuro-stimulator to revolutionise patient care: Many neurological disorders like Parkinson’s, chronic depression and other psychiatric conditions could be managed at home, thanks to a collaborative project involving researchers at the University of Queensland (UQ). Queensland Brain Institute (QBI) Professor Peter Silburn AM said his team, together with Neurosciences Queensland and Abbott Neuromodulation have developed […]
Read More… from Wireless neuro-stimulator to revolutionise care
Red wine and berries could improve life expectancy for those with Parkinson’s: Recent research has found, for the first time, that people with Parkinson’s disease who eat more flavonoids—compounds found in foods like berries, cocoa, tea and red wine—may have improved life expectancy compared to those who don’t. The research followed up over 1,200 people […]
Read More… from Red wine and berries could improve life expectancy for those with Parkinson’s
Disease-modifying antirheumatic drugs do not seem to protect people with rheumatoid arthritis against Parkinson’s disease. The autoimmune disorder rheumatoid arthritis has been associated with a lower risk of Parkinson’s disease (PD) in previous studies, with antirheumatic drugs as one possible explanation. However, most of the disease-modifying antirheumatic drugs (DMARDs) were not associated with the risk […]
Read More… from Disease-modifying antirheumatic drugs and Parkinson Disease
Parkinson’s Disease expert nursing appointment: A RENOWNED expert on Parkinson’s Disease has been appointed the North East and North Cumbria’s first Clinical Academic Professor in Nursing – one of the first key roles of its type in the UK. Dr Annette Hand will take up the flagship clinical chair post – a joint position between […]
Read More… from Parkinson’s Disease expert nursing appointment
A revolutionary approach to targeting and treating walking problems in people with Parkinson’s disease is being developed at Northumbria University, Newcastle. Problems, such as slow and short steps, are very common in Parkinson’s disease and lead to increased risks of falling, as well as reduced mobility and quality of life. However, there is no medication […]
Read More… from Parkinson’s disease: Transforming treatments